WESPAC Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1484540 ORINDA, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,400,934

+$948,408 QoQ

Shares Held

1,168

+137.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.67%

of 13F equity value

Holder Rank

#2,835

of 4,605 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WESPAC Advisors, LLC holds $6,216,166 across 5 Drug Manufacturers - General names. LLY ranks #2 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	27,798	$3,572,043
2	LLY	ELI LILLY & Co This page	1,168	$1,400,934
3	AMGN	Amgen Inc	2,087	$755,744
4	GILD	Gilead Sciences, Inc.	2,272	$287,044
5	GSK	GSK plc	3,823	$200,401

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,400,934	1,168	+137.4%	Shares	Sole	2026-08-10
2026-03-31	$452,526	492	-7.5%	Shares	Sole	2026-04-29
2025-12-31	$571,729	532	-7.6%	Shares	Sole	2026-01-14
2025-09-30	$439,488	576	0.0%	Shares	Sole	2025-10-27
2025-06-30	$449,009	576	0.0%	Shares	Sole	2025-07-23
2025-03-31	$475,724	576	-25.6%	Shares	Sole	2025-05-01
2024-12-31	$597,528	774	-68.5%	Shares	Sole	2025-02-04
2024-09-30	$2,178,526	2,459	+3.5%	Shares	Sole	2024-11-12
2024-06-30	$2,150,277	2,375	-16.9%	Shares	Sole	2024-07-30
2024-03-31	$2,224,187	2,859	+12.7%	Shares	Sole	2024-04-24
2023-12-31	$1,478,868	2,537	+16.2%	Shares	Sole	2024-01-26
2023-09-30	$1,173,091	2,184	+22.2%	Shares	Sole	2023-10-26
2023-06-30	$838,067	1,787	0.0%	Shares	Sole	2023-07-28
2023-03-31	$613,691	1,787	-35.2%	Shares	Sole	2023-04-27
2022-12-31	$1,009,352	2,759	+3.8%	Shares	Sole	2023-02-01
2022-09-30	$859,787	2,659	+104.5%	Shares	Sole	2022-10-18
2021-03-31	$242,866	1,300	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.